These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis. Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660 [TBL] [Abstract][Full Text] [Related]
33. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy. Shephard SE; Panizzon RG Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574 [TBL] [Abstract][Full Text] [Related]
34. Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters. Marrakchi S; Decloquement L; Pollet P; Briand G; Loesche C; Bocquet JL; Degand P; Thomas P Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):206-11. PubMed ID: 1822684 [TBL] [Abstract][Full Text] [Related]
35. Bath-5-methoxypsoralen-UVA therapy for psoriasis. Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060 [TBL] [Abstract][Full Text] [Related]
36. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis. Collins P; Rogers S Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760 [TBL] [Abstract][Full Text] [Related]